• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富马酸替诺福韦艾拉酚胺单盐的单晶结构:一种包含共晶和盐的亚稳相。

On the Single-Crystal Structure of Tenofovir Alafenamide Mono-Fumarate: A Metastable Phase Featuring a Mixture of Co-Crystal and Salt.

机构信息

Department of Chemistry, Zhejiang University, Hangzhou 310028, China.

College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China.

出版信息

Int J Mol Sci. 2020 Dec 3;21(23):9213. doi: 10.3390/ijms21239213.

DOI:10.3390/ijms21239213
PMID:33287166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7730268/
Abstract

Tenofovir alafenamide (TAF) is a prodrug of tenofovir as a potent nucleotide reverse transcriptase inhibitor. It serves as the key component of Genvoya for the first-line treatment of human immunodeficiency virus infection (HIV) and is the active component of Vemlidy for the treatment of chronic hepatitis B. Vemlidy is also a monotherapeutic regimen formulated as TAF hemifumarate (; TAF:fumarate = 2:1). In this work, we report for the first time the single-crystal structure of TAF fumarate hemihydrate (, TAF:fumarate:HO = 2:2:1). Compound is initially documented as a salt in which one proton of the fumaric acid migrates to the amine group of the adenine moiety in TAF. It was recently proposed that ca. 20-30% proton is transferred to the N atom on the aromatic adenine backbone. We herein provide definitive single-crystal X-ray diffraction results to confirm that , though phase pure, is formed as a mixture of co-crystal (75%) and salt (25%). It features two pairs of TAF fumarates, wherein one of the four H atoms on the fumaric acid is transferred to the N atom of the adjacent adenine moiety while the other three carboxylates remain in their intrinsic acid form. Compound is a metastable phase during the preparation of and can be isolated by halting the reaction during the refluxing of TAF and fumaric acid in acetonitrile (MeCN). Our report complements the previous characterizations of TAF monofumarate, and its elusive structural patterns are finally deciphered.

摘要

替诺福韦艾拉酚胺(TAF)是替诺福韦的前药,作为一种有效的核苷酸逆转录酶抑制剂。它是用于人类免疫缺陷病毒感染(HIV)一线治疗的 GENVOYA 的关键成分,也是用于治疗慢性乙型肝炎的 VEMLIDY 的活性成分。VEMLIDY 也是一种单药治疗方案,其配方为 TAF 富马酸半酯(;TAF:富马酸 = 2:1)。在这项工作中,我们首次报道了 TAF 富马酸半水合物(,TAF:富马酸:HO = 2:2:1)的单晶结构。化合物最初被记录为一种盐,其中富马酸的一个质子迁移到 TAF 中腺嘌呤部分的氨基上。最近有人提出,大约 20-30%的质子转移到芳香腺嘌呤主链上的 N 原子上。我们在此提供明确的单晶 X 射线衍射结果,以确认,尽管是纯相的,但它是由共晶(75%)和盐(25%)的混合物形成的。它具有两对 TAF 富马酸盐,其中富马酸的四个 H 原子中的一个转移到相邻腺嘌呤部分的 N 原子上,而其余三个羧酸盐保持其固有酸形式。化合物在 TAF 和富马酸在乙腈(MeCN)中的回流过程中制备时是一种亚稳相,可以通过在回流过程中停止反应来分离。我们的报告补充了 TAF 单富马酸盐的先前特征,其难以捉摸的结构模式终于被破解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/45061ec04bf1/ijms-21-09213-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/43f35f20c5de/ijms-21-09213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/60b5e7075ad7/ijms-21-09213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/2ee67468c512/ijms-21-09213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/a2c5a8f666c8/ijms-21-09213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/24682be5ec67/ijms-21-09213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/aaed22512523/ijms-21-09213-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/c6a3ad7b86b5/ijms-21-09213-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/6991885a748f/ijms-21-09213-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/45061ec04bf1/ijms-21-09213-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/43f35f20c5de/ijms-21-09213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/60b5e7075ad7/ijms-21-09213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/2ee67468c512/ijms-21-09213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/a2c5a8f666c8/ijms-21-09213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/24682be5ec67/ijms-21-09213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/aaed22512523/ijms-21-09213-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/c6a3ad7b86b5/ijms-21-09213-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/6991885a748f/ijms-21-09213-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea4/7730268/45061ec04bf1/ijms-21-09213-g009.jpg

相似文献

1
On the Single-Crystal Structure of Tenofovir Alafenamide Mono-Fumarate: A Metastable Phase Featuring a Mixture of Co-Crystal and Salt.富马酸替诺福韦艾拉酚胺单盐的单晶结构:一种包含共晶和盐的亚稳相。
Int J Mol Sci. 2020 Dec 3;21(23):9213. doi: 10.3390/ijms21239213.
2
Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.共晶体、盐类还是两者的混合物?替诺福韦艾拉酚胺富马酸盐的情况
Pharmaceutics. 2020 Apr 10;12(4):342. doi: 10.3390/pharmaceutics12040342.
3
High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarate.与富马酸替诺福韦二吡呋酯相比,替诺福韦艾拉酚胺的高耐药屏障是由更多的二磷酸替诺福韦进入靶细胞所驱动的。
Antiviral Res. 2016 Aug;132:50-8. doi: 10.1016/j.antiviral.2016.05.012. Epub 2016 May 18.
4
Population Pharmacokinetics of Tenofovir Alafenamide Fumarate and Its Metabolite Tenofovir in Healthy Chinese Volunteers.富马酸替诺福韦艾拉酚胺及其代谢物替诺福韦在中国健康志愿者中的群体药代动力学。
Clin Pharmacol Drug Dev. 2024 Feb;13(2):168-179. doi: 10.1002/cpdd.1340. Epub 2023 Nov 12.
5
Interspecies Differences in Tenofovir Alafenamide Fumarate Stability in Plasma.富马酸替诺福韦艾拉酚胺在血浆中的种间稳定性差异。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00930-20.
6
Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate.在初治的HIV-1感染受试者中,使用埃替格韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺或埃替格韦/考比司他/恩曲他滨/替诺福韦酯进行96周治疗后耐药性出现频率较低。
Antivir Ther. 2017;22(5):443-446. doi: 10.3851/IMP3125. Epub 2017 Jan 11.
7
Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.富马酸替诺福韦艾拉酚胺:一种用于治疗慢性乙型肝炎感染的新型替诺福韦前药
J Infect Dis. 2017 Nov 16;216(suppl_8):S792-S796. doi: 10.1093/infdis/jix135.
8
Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate.抗逆转录病毒药物及其组合的稳定性行为。4:富马酸替诺福韦艾拉酚胺降解产物的表征及其与富马酸替诺福韦酯降解和稳定性行为的比较。
J Pharm Biomed Anal. 2016 Nov 30;131:146-155. doi: 10.1016/j.jpba.2016.08.022. Epub 2016 Aug 26.
9
Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors.替诺福韦艾拉酚胺的细胞内激活及病毒和宿主蛋白酶抑制剂的作用
Antimicrob Agents Chemother. 2015 Oct 26;60(1):316-22. doi: 10.1128/AAC.01834-15. Print 2016 Jan.
10

引用本文的文献

1
Glasdegib Dimaleate: Synthesis, Characterization and Comparison of Its Properties with Monomaleate Analogue.二马来酸格拉斯吉布:合成、表征及其与单马来酸类似物的性质比较
Pharmaceutics. 2022 Aug 6;14(8):1641. doi: 10.3390/pharmaceutics14081641.

本文引用的文献

1
Zinc and Cadmium Complexes of Pyridinemethanol Carboxylates: Metal Carboxylate Zwitterions and Metal-Organic Frameworks.吡啶甲醇羧酸盐的锌和镉配合物:金属羧酸盐两性离子和金属有机框架
Chempluschem. 2020 May;85(5):832-837. doi: 10.1002/cplu.202000175.
2
Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.共晶体、盐类还是两者的混合物?替诺福韦艾拉酚胺富马酸盐的情况
Pharmaceutics. 2020 Apr 10;12(4):342. doi: 10.3390/pharmaceutics12040342.
3
Metal-Organic Frameworks via Emissive Metal-Carboxylate Zwitterion Intermediates.
通过发射性金属羧酸盐两性离子中间体制备金属有机框架材料。
Chempluschem. 2015 Aug;80(8):1231-1234. doi: 10.1002/cplu.201500134. Epub 2015 Jun 3.
4
Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.HIV DNA 疫苗研发的最新进展:临床试验的逐步改进。
J Control Release. 2019 Dec 28;316:116-137. doi: 10.1016/j.jconrel.2019.10.045. Epub 2019 Nov 11.
5
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials.艾维雷韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺治疗亚洲人类免疫缺陷病毒1型感染患者的疗效和安全性:一项3期临床试验的亚组分析
HIV Res Clin Pract. 2019 Jun;20(3):73-81. doi: 10.1080/15284336.2019.1589232. Epub 2019 Jul 8.
6
Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?替诺福韦艾拉酚胺(TAF)治疗乙型肝炎病毒(HBV),有哪些未解决的问题?
Expert Rev Anti Infect Ther. 2018 Feb;16(2):153-161. doi: 10.1080/14787210.2018.1428561. Epub 2018 Jan 23.
7
Deciphering the Structural Relationships of Five Cd-Based Metal-Organic Frameworks.解析五种镉基金属有机框架的结构关系
Inorg Chem. 2017 Jun 5;56(11):6522-6531. doi: 10.1021/acs.inorgchem.7b00592. Epub 2017 May 11.
8
Candidates for inclusion in a universal antiretroviral regimen: tenofovir alafenamide.纳入通用抗逆转录病毒治疗方案的候选药物:替诺福韦艾拉酚胺。
Curr Opin HIV AIDS. 2017 Jul;12(4):324-333. doi: 10.1097/COH.0000000000000379.
9
The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.替诺福韦艾拉酚胺与富马酸替诺福韦二吡呋酯在抗逆转录病毒治疗方案中用于HIV-1治疗的疗效和安全性:荟萃分析。
Medicine (Baltimore). 2016 Oct;95(41):e5146. doi: 10.1097/MD.0000000000005146.
10
Retroviral DNA Integration.逆转录病毒DNA整合
Chem Rev. 2016 Oct 26;116(20):12730-12757. doi: 10.1021/acs.chemrev.6b00125. Epub 2016 May 20.